Why the Calcium Dose and Form You Take Matters More Than the Total

Shilajit's own 48-week human trial found something calcium never has, bone density itself moving in the opposite direction from placebo in postmenopausal women. That result raises an obvious question about the mineral aisle standing next to it. If a specific mechanism can reverse density and generic calcium cannot, is calcium worth taking at all, and if so, in what amount and what form. Real absorption research and a separate line of vitamin K2 trials both point at a more precise, more honest answer than "take more."
What did the biggest calcium trial ever run actually find?
The standard advice for decades has been simple. Take calcium, take vitamin D, protect your bones. A 2017 meta-analysis tested that advice at a scale nothing else has matched, pooling 33 randomized trials and 51,145 community-dwelling adults over 50.
The result was null. No significant reduction in hip fracture risk from calcium alone, vitamin D alone, or the two combined. A separate 25,871-person trial in 2022 found the same thing for vitamin D on its own. The authors of the larger analysis wrote that their findings "do not support the routine use of these supplements."
That is the evidence a woman has likely been following for years, and it was never built to move the outcome she actually cares about. It does not mean calcium and vitamin D are useless. It means the old answer was incomplete in a specific, measurable way, and the newer research fills in two of the missing pieces.
Why does a smaller calcium dose absorb a bigger share?

Absorption research settled this decades ago, and it rarely makes it into the conversation. A classic human study measured calcium absorption in healthy adult women across doses from 15 to 500 milligrams, given with meals.
- At the smallest tested loads, women absorbed an average of 64.0% of the calcium
- At 500 milligrams, absorption fell to an average of 28.6%
- The relationship was a strong, statistically significant curve, smaller doses absorbed as a consistently higher percentage
The number that gets left out of most labels
A single dose does not have to be large to work. It has to sit in the range where the body still absorbs a meaningful share of it. 210 milligrams sits in the lower half of the tested range, closer to the high-absorption end than to the 500-milligram mark where the curve had already fallen to under 30%. That is not the same as saying 210 milligrams is the one optimal number. Total absorbed calcium still rises with a bigger dose even as the percentage falls. It is a real, measured tradeoff, not a marketing round number.
What does vitamin K2 actually do that calcium alone does not?

Calcium's job is supplying the mineral. Vitamin K2's job, according to a cluster of controlled human trials, is directing where that mineral goes once it is circulating.
A specific protein, osteocalcin, has to be chemically activated, carboxylated, before it can bind calcium into bone matrix. Several trials measured this directly.
- A dose-finding trial in postmenopausal women found 100 micrograms of MK-7 significantly raised the activated fraction of osteocalcin, while 50 micrograms did not
- A separate trial at 90 micrograms significantly reduced femoral-neck bone loss in postmenopausal women over one year
- A three-year, 244-woman trial at a higher 180-microgram dose slowed the age-related decline in spine and femoral-neck density, though not at the hip
- The same three-year trial found MK-7 improved a marker of arterial flexibility, though this remains a single trial and is not treated here as a heart-protection promise
None of this is a bone-building claim on its own. It is evidence that the calcium already circulating in the body needs a specific vitamin K signal to end up in the right place, a mechanism calcium and vitamin D supplementation alone does not address.
The dose that matters, stated honestly
Optimum's Calcium D3 plus K2 carries 100 micrograms of MK-7, which lands directly on the dose the finding above identified as the threshold where the effect became significant. The higher-dose trials above, at 180 and 375 micrograms, found stronger density results than the lower doses did. Those larger results belong to those larger doses and are never attached to this product's 100-microgram amount.
Does stacking calcium, D3, and K2 together work better?
Not automatically, and one trial found the opposite of what a supplement label would suggest.
A 311-person, one-year trial randomized people to placebo, 50 micrograms of K2, 90 micrograms of K2, or 90 micrograms of K2 plus calcium and vitamin D3. Adding the calcium and D3 to the K2 dose produced no additional benefit over K2 taken alone in that trial. The honest reason to combine all three ingredients in one capsule is practical rather than a synergy claim, one capsule instead of three, and vitamin D3 is what lets the calcium already there be absorbed in the first place.
Calcium needs vitamin D to be absorbed. Vitamin K2 needs a reason to exist that calcium alone does not supply. Neither substitutes for the other, and neither's evidence gets borrowed to inflate the third.
Is Optimum's Calcium D3 plus K2 allowed to claim bone protection?
No, and here is exactly where the honest line sits.
- This product never claims to build bone density, prevent fractures, or reverse osteoporosis
- Its claim ceiling is absorption of the calcium dose itself and vitamin K2's role in directing that calcium once absorbed
- One of the K2 trials cited above is funded by a company that sells MK-7, disclosed here rather than left out
- Every trial in this section measured a biomarker or a density number, never an actual fracture prevented
That ceiling is not a hedge added after the fact. It is the same standard this article has applied to every result in it, calcium's own null trial included.
Here is the honest before-and-after, side by side.
| Approach | What it claims | What the evidence actually shows |
|---|---|---|
| Standard calcium plus D, large single dose | Lowers fracture risk | No significant reduction across 51,145 adults pooled |
| Smaller, meal-timed calcium dose | Absorbs a higher share | 64.0% absorbed at low doses vs 28.6% at 500 mg, same women |
| Vitamin K2 at 90 to 100 mcg | Directs calcium into bone matrix | Significantly raised activated osteocalcin, reduced femoral-neck bone loss |
| All three combined | Assumed synergy | One 311-person trial found no added benefit from calcium and D3 on top of K2 alone |
Where does shilajit fit into the mineral picture?

Shilajit's own 48-week trial in 60 postmenopausal women measured something none of the calcium or K2 research above measured directly, actual bone density reversing course by the six-month mark, alongside markers moving in the antiresorptive direction and inflammation falling.
That is a different mechanism than the one this article has spent most of its length on. Calcium supplies material. Vitamin D lets it be absorbed. Vitamin K2 directs it once it is there. Shilajit's own trial addresses the density outcome directly, at a different biological level than any of the mineral research above reaches. No source here claims the two work through the same pathway, and no result from one is borrowed to inflate the other.
Common questions about calcium dose, form, and vitamin K2
Does Optimum's Calcium D3 plus K2 build bone density or prevent fractures?
No, and this article does not claim that. The evidence behind this product supports absorption and vitamin K's role in directing calcium, not bone-building or fracture prevention. No trial cited here tested our exact capsule against a fracture outcome.
Why is the calcium dose only 210 milligrams, when other supplements sell 600 or more?
Human research on calcium absorption found the fraction of a dose your body actually absorbs falls as the size of the single dose rises. A smaller dose is absorbed as a higher percentage, even though total absorbed calcium still grows with a bigger dose. This product is built around the lower, more efficiently absorbed end of that range.
Does adding calcium and vitamin D on top of vitamin K2 make it work better?
One trial found the opposite. Adding calcium and vitamin D3 to a K2 dose gave no additional benefit beyond K2 alone in that specific trial. We say this plainly rather than imply a synergy the evidence does not support.
Is this the same as shilajit's own bone research?
No. Shilajit's own 48-week trial measured bone density itself reversing in postmenopausal women. This product addresses a different, narrower question, how well a mineral dose absorbs and what vitamin K2 does with the calcium already in the body. The two mechanisms are kept separate throughout this article.

Optimum's Calcium D3 plus K2
A smaller, better-absorbed calcium dose alongside the vitamin K2 amount research has actually tested. Optimum's Calcium D3 plus K2 is built as a companion to the bone line, one capsule a day, at doses the research above can actually speak to.
See Optimum's Calcium D3 plus K2Sources
- Zhao JG, et al. Association between calcium or vitamin D supplementation and fracture incidence in community-dwelling older adults. JAMA 2017;318(24):2466-2482. https://pubmed.ncbi.nlm.nih.gov/29279934/
- LeBoff MS, et al. Supplemental vitamin D and incident fractures in midlife and older adults. N Engl J Med 2022;387(4):299-309. https://pubmed.ncbi.nlm.nih.gov/35939577/
- Heaney RP, Weaver CM, Fitzsimmons ML. Influence of calcium load on absorption fraction. J Bone Miner Res 1990;5(11):1135-1138. https://pubmed.ncbi.nlm.nih.gov/2270776/
- Inaba N, Sato T, Yamashita T. Low-dose menaquinone-7 and osteocalcin carboxylation in postmenopausal women. J Nutr Sci Vitaminol 2015;61(6):471-480. https://pubmed.ncbi.nlm.nih.gov/26875489/
- Zhang Y, et al. Low-dose vitamin K2 and bone mineral density in older adults. Calcif Tissue Int 2020;106(5):476-485. https://pubmed.ncbi.nlm.nih.gov/32060566/
- Knapen MH, et al. Three-year low-dose menaquinone-7 supplementation and bone loss in postmenopausal women. Osteoporos Int 2013;24(9):2499-2507. https://pubmed.ncbi.nlm.nih.gov/23525894/
- Knapen MH, et al. Menaquinone-7 supplementation and arterial stiffness in healthy postmenopausal women. Thromb Haemost 2015;113(5):1135-1144. https://pubmed.ncbi.nlm.nih.gov/25694037/
- Heaney RP. Vitamin D and calcium interactions, functional outcomes. Am J Clin Nutr 2008;88(2):541S-544S. https://pubmed.ncbi.nlm.nih.gov/18689398/
- Pingali U, et al. Efficacy and safety of purified Shilajit in postmenopausal women with osteopenia. J Ayurveda Integr Med 2022. https://pubmed.ncbi.nlm.nih.gov/35933897/